Dr. Hannes Schihada

About Dr. Hannes Schihada

Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin Lohse at the Institute of Pharmacology & Toxicology in Würzburg, Germany, in 2015. My project involved the development of FRET/BRET-based GPCR conformational biosensors, which can be employed in high throughput ligand screening.

After my Ph.D. defense in 2019, I moved with a DFG (German research council) PostDoc fellowship to Stockholm, Sweden, in order to focus my research on class Frizzled GPCRs in the lab of Gunnar Schulte at the Karolinska Institute. I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors, allowing us to better understand their mode of action.

By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb in Marburg. I was recently awarded a Marie Sklodowska Curie PostDoc Fellowship in order to investigate and find better ligands for the orphan class A GPCRs, GPR3, GPR6, and GPR12.